期刊文献+

系统性红斑狼疮患者外周血内皮祖细胞的实验研究 被引量:2

The experimential study of peripheral endothelial progenitor cells in patients with systemic lupus erythematosus
下载PDF
导出
摘要 目的探讨系统性红斑狼疮患者外周血内皮祖细胞(EPC)数量、功能是否改变。方法连续选入33例系统性红斑狼疮(SLE)患者做为SLE组,33名门诊健康体检者为对照组。流式细胞分析计量外周血CD34和KDR双阳性细胞,同时原代培养EPC,培养7 d后MTT法检测增殖能力,改良boydon小室法检测迁移能力。结果SLE组外周血EPC数量较对照组显著减少,P<0.01;SLE组的增殖、迁移能力均较对照组减弱,P<0.01。结论系统性红斑狼疮患者外周血EPC数量减少,增殖、迁移功能降低,可能是SLE促动脉粥样硬化发生的机制之一。 Objective To determine whether the number and function of endothelial progentor EPC are altered in patients with cells systemic lupus erythematosus.Methods Thirty-three patients with SLE and 33 controls were analysed.Peripheral EPC was enumerated as CD34+/KDR+ cell via fluorescence-activated cell sorter analysis.Additionally,EPCs were isolated and cultured in vitro for 7 days,then EPCs proliferation activities were performed by MTT assay and migration activities were determined by modified Boyden chamber assay.Results CD34+/KDR+ cells were decreased in SLE(P〈0.01).In addition,EPCs from patients with SLE are significantly damaged in their proliferation(P〈0.01)and migration capacity compared with controls.Conclusions Our results suggest that the number and activities of peripheral EPCs were lower in patients with SLE.It may reduce the ability to repair vascular damage and thus may trigger the development of atherosclerosis in SLE.
作者 陈小强
机构地区 解放军第
出处 《局解手术学杂志》 2010年第2期96-97,共2页 Journal of Regional Anatomy and Operative Surgery
关键词 系统性红斑狼疮 内皮祖细胞 实验研究 systemic lupus erythematosus endothelial progenitor cells experimental study
  • 相关文献

参考文献1

二级参考文献8

  • 1Lee SJ, Kim KM, Namkoong S, et al. Nitric oxide inhibition of homocysteine-induced human endothelial cell apoptosis by down-regulation of p53-dependent Noxa expression through the formation of Snitrosohomocysteine [ J ]. J Biol Chem, 2005, 280 ( 7 ) :5781-5788.
  • 2Alvarez-Maqueda M, El Bekay R, Monteseirin J, et al. Homocysteine enhances superoxlde anion release and NADPH oxidase assembly by human neutrephils. Effects on MAPK activation and neutrophil migration[ J]. Atherosclerosis, 2004, 172(2) :229-238.
  • 3Wassmann S, Laufs U, Mailer K. Cellular antioxidant effects of atorvastatin in vitro and in vivo[J]. Arterioscler Thromb Vase Biol, 2002, 22 (2) : 300-305.
  • 4Ten Freyhaus H, Huntgeburth M, Wingler K. Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation[J]. Cardiovasc Res, 2006, 71 (2) :331- 341.
  • 5Mohsen Kerkenl, Mehdi Tnani, Laurence Chuniaud, et al. Comparative study on in vitro effects of homocysteine thiotactone and homocysteine on HUVEC cells : Evidence for a stronger proapoptotic and proinflammative homocysteine thiolactone [ J ]. Mol Cell Biochem, 2006, 291 (1-2) :119-126.
  • 6Au-Yeung KK, Woo CW, Sung FL, et al. Hyperhomocysteinemia activates nuclear factor-kappaB in endothelial cells via oxidative stress[ J]. Circ Res ,2004,94( 1 ) :28-36.
  • 7Rubba P. Effects of atorvastatin on the different phases of atherogenesis[J]. Drugs, 2007, 67(Suppll ) :17-27.
  • 8Goettsch C, Goettsch W, Muller G. Noxg overexpression activates reactive oxygen species and p38 MAPK in human endothelial cells [J]. Biochem Biophys Res Commun, 2009, 380(2) :355-360.

共引文献5

同被引文献12

  • 1杨春兰,沈荣春,徐云,鞠少卿,王惠民.系统性红斑狼疮患者血清IL-6水平与抗ENA多肽抗体谱的关系[J].现代检验医学杂志,2007,22(2):120-121. 被引量:2
  • 2Agnello V,Koffler D,Eisenberg JW,et al.C1q precipitins in the sera of patients with systemic lupus erythematosus and other hypocoplementemic states:characterization of high and low molecular weight types[J].J Exp Med,1971,134(3Pt2):228s-241s.
  • 3Uwatoko S,Mannik M.Low-molecular weight C1q-binding immunoglobulin G in patients with systemic lupus erythematosus consists of autoantibodies to the collagen-like region of C1q[J].J Clin Invest,1988,82(3):816-824.
  • 4Ravirajan CT,Rowse L,MacGowan JR.An analysis of clinical disease activity and nephritis associated serum autoantibodies profiles in patients with systemic lupus erythematosus:a cross-sectional study[J].Rheumatolog,2001,40(12):1405-1412.
  • 5Moroni G,Radice A,Giammarresi G.Are laboratory tests useful for monitoring the activity of lupus nephritis?A 6-year prospective study in a cohort of 228 patients with lupus nephritis[J].Ann Rheum Dis,2009,68(2):234-237.
  • 6Houssiau FA,Vasconcelos C,D′Cruz D.Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis:lessons from long-term follow-up of patients in the Euro-Lupus Nephritis Trial[J].Arthritis Rheum,2004,50(12):3934-3940.
  • 7Marto N,Bertolaccini M,Calabuig E,et al.Anti-C1q antibodies in nephritis:correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus[J].Ann Rheum Dis,2005,64(3):444-448.
  • 8Austin HA 3rd,Muenz LR,Joyce KM,et al.Diffuse proliferative lupus nephritis:identification of specific pathologic features affecting renal outcome[J].Kidney Int,1984,25(4):689-695.
  • 9陈兴国,张小利,刘春燕,曹继伟,杜同信,王自正.系统性红斑狼疮患者血清抗dsDNA抗体的表达水平变化及临床意义分析[J].放射免疫学杂志,2008,21(1):6-8. 被引量:18
  • 10王茜,潘海峰,李文先,叶冬青.IgG型抗dsDNA抗体及其亚型与狼疮肾炎临床和病理关系探讨[J].中华疾病控制杂志,2008,12(5):420-424. 被引量:9

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部